Blanc-Potard A B, Gari E, Spirito F, Figueroa-Bossi N, Bossi L
Centre de Génétique Moléculaire du Centre National de la Recherche Scientifique Associé à l'Université P. et M. Curie, Gif-sur-Yvette, France.
Mol Gen Genet. 1995 Jun 25;247(6):680-92. doi: 10.1007/BF00290399.
Some rifampicin-resistance (RifR) mutations make bacteria slightly resistant to the gyrase inhibitors novobiocin (Nov) and nalidixic acid (Nal). This suggested that it might be possible to isolate rpoB mutants using either drug for positive selection. In an initial test, we confirmed the presence of Rif-resistant isolates among clones selected for Nov resistance. These mutants are also more resistant to Nal. In a subsequent experiment, we found that mutants selected for low-level resistance to Nal include isolates harboring mutations genetically linked to the rpoB locus; of two such mutants studied, one is temperature-sensitive for growth. These two mutants, which are only marginally affected in their response to Nov, are normally sensitive to Rif and thus might be representative of a new class of rpoB alleles. The Rif-resistant and Rif-sensitive rpoB alleles that increase resistance to gyrase inhibitors have one property in common: they all suppress, to varying degrees, the defect in his operon regulation (transcriptional deattenuation) caused by a gyrase defect or inhibition by novobiocin. To further analyse the transcription-supercoiling relationships in these mutants, we examined the ability of RNA polymerase to recruit gyrase activity during transcription. This was done by two independent approaches: (i) observing transcription-induced accumulation of hyper-negatively supercoiled plasmid DNA in a topA mutant background and (ii) measuring transcription-induced plasmid DNA cleavage in the presence of oxolinic acid. Results indicate that the rpoB alleles described in this study diminish the recruitment of gyrase activity by the transcription process. This property correlates with a decrease in the rate of transcription initiation.(ABSTRACT TRUNCATED AT 250 WORDS)
一些利福平耐药(RifR)突变使细菌对回旋酶抑制剂新生霉素(Nov)和萘啶酸(Nal)产生轻微耐药性。这表明有可能使用这两种药物中的任何一种进行阳性筛选来分离rpoB突变体。在初步试验中,我们证实了在选择对Nov耐药的克隆中存在利福平耐药菌株。这些突变体对Nal也更具耐药性。在随后的实验中,我们发现选择对Nal具有低水平耐药性的突变体包括携带与rpoB基因座遗传连锁突变的菌株;在研究的两个此类突变体中,一个对生长温度敏感。这两个突变体对Nov的反应仅受到轻微影响,通常对利福平敏感,因此可能代表一类新的rpoB等位基因。增加对回旋酶抑制剂耐药性的利福平耐药和利福平敏感的rpoB等位基因有一个共同特性:它们都不同程度地抑制由回旋酶缺陷或新生霉素抑制引起的组氨酸操纵子调控缺陷(转录去衰减)。为了进一步分析这些突变体中的转录 - 超螺旋关系,我们研究了RNA聚合酶在转录过程中募集回旋酶活性的能力。这通过两种独立的方法完成:(i)观察在topA突变体背景中转录诱导的超负超螺旋质粒DNA的积累,以及(ii)在恶唑酸存在下测量转录诱导的质粒DNA切割。结果表明,本研究中描述的rpoB等位基因减少了转录过程对回旋酶活性的募集。这一特性与转录起始速率的降低相关。(摘要截短于250字)